Item 5.07 Submission of Matter to a Vote of Security Holders

On June 9, 2021, Fuse Medical, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders (the "Annual Meeting"). The total number of shares of common stock eligible to vote as of the record date, April 14, 2021, was 73,124,458 and, pursuant to the Company's Bylaws, 36,562,230 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of shares of common stock present or represented at the Annual Meeting was 66,190,678, and a quorum therefore existed.

At the Annual Meeting:

1. Election of Board of Directors. The following persons were elected as

directors of the Company for a one-year term expiring at the 2022 Annual

Meeting of Stockholders with the following vote:




Name                       Votes For  Votes Against Votes Withheld  Broker
                                                                   Non-Votes
Renato V. Bosita, Jr., MD  64,700,611       0           72,230     1,417,837
Mark W. Brooks             64,700,642       0           72,199     1,417,837
William E. McLaughlin, III 64,698,148       0           74,693     1,417,837
Christopher C. Reeg        64,700,648       0           72,193     1,417,837


2.  Ratification of the Selection of Armanino LLP ("Armanino"). The selection of
    Armanino to act as independent registered public accounting firm for the
    Company for the fiscal year ending December 31, 2021 was ratified by a vote
    of (i) 66,147,916 in favor, (ii) 42,762 against, and (iii) zero abstaining.




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses